Design and experimental demonstration of a beam scanning lens antenna.

A beam scanning antenna based on an all-metal lens is presented for high-power microwave (HPM) application in this paper. This design includes a feed antenna and two layers of different all-metal lenses, whose prototypes operating at 14.25 GHz have been successfully designed and fabricated with an aperture radius of 300 mm.

A dielectric embedded reflectarray for high-power microwave application.

To solve the problem of the large axial size of high-power microwave (HPM) reflectarray antenna and difficulty in vacuum packaging, a dielectric is introduced in the design of the antenna element. On this basis, a dielectric embedded metasurface reflectarray antenna (DEMRA) with high power handling capacity and wide-range beam scanning capability is proposed and fabricated. Compared with traditional HPM antennas, the DEMRA does not need to be sealed and can work directly in open-air conditions.

A long-pulse repetitive operation magnetically insulated transmission line oscillator.

The improved magnetically insulated transmission line oscillator (MILO) is a gigawatt-class L-band high power microwave tube. It has allowed us to generate 3.1 GW pulse of 40 ns duration in the single-pulse operation and 500 MW pulse of 25 ns duration in the repetition rate operation.

Recent progress of the improved magnetically insulated transmission line oscillator.

The improved magnetically insulated transmission line oscillator (MILO) is a gigawatt-class L-band high power microwave tube driven by a 550 kV, 57 kA, 50 ns electron beam. It has allowed us to generate 2.4 GW pulse of 22 ns duration.

Retrospective analysis of 18 cases of antithyroid drug (ATD)-induced agranulocytosis.

In this study, we retrospectively analyzed 18 patients in whom antithyroid drug (ATD)-induced agranulocytosis developed during treatment of Graves' disease. All patients were more than 20 years of age, and we saw no correlation between age and the development of agranulocytosis. In 17 of 18 patients, ATD-induced agranulocytosis developed within 2 to 12 weeks of starting ATD treatment.